AMRN FY 2013 Earnings — Amarin Corporation plc Revenue & Financial Results | Market Cap Arena

AMRNAmarin Corporation plc

$338M

FY 2013 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$26M

Gross Profit

$14M54.8% margin

Operating Income

-$182M-691.1% margin

Net Income

-$166M-630.8% margin

EPS (Diluted)

$-25.60

Cash Flow

Operating Cash Flow

-$190M

Free Cash Flow

-$190M

Stock-Based Comp.

$11M

Balance Sheet

Total Assets

$252M

Total Liabilities

$286M

Stockholders' Equity

-$34M

Cash & Equivalents

$192M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$26M	$0	—
Gross Profit	$14M	$0	—
Operating Income	-$182M	-$117M	-56.0%
Net Income	-$166M	-$179M	+7.2%